November 03, 2020
Express Scripts Pharmacy did NOT dispense any lots impacted by this recall.
On November 2, 2020, Nostrum Laboratories, Inc announced a voluntary recall of 2 lots (MET200101, Exp 5/2022 and MET200301 Exp 5/2022) of Metformin Hydrochloride Extended-Release Tablets, USP 750mg. These lots were found to contain levels of NDMA, an unexpected impurity, at levels in excess of acceptable limits. Nostrum Laboratories has not received any reports of adverse events related to this recall.
Patients who have confirmed receipt of a recalled lot should consult a healthcare professional to obtain a replacement or a different treatment option. It could be dangerous for patients with type 2 diabetes to stop taking their metformin without first talking to their healthcare professional. Patients should contact their physician or healthcare provider if they have experienced any problems that may be related to taking this drug product.
Patients with medical questions regarding this recall can contact Nostrum Laboratories, Inc. Medical Affairs at phone number 816-308-4941 or email email@example.com Monday through Friday from 8am – 5 pm CST. Consumers should contact their physician or pharmacy for further medical advice.
Additional information is available on the FDA’s website:
Last updated: November 03, 2020